These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10320836)

  • 41. Left ventricular abnormalities in children, adolescents and young adults with renal disease.
    Johnstone LM; Jones CL; Grigg LE; Wilkinson JL; Walker RG; Powell HR
    Kidney Int; 1996 Sep; 50(3):998-1006. PubMed ID: 8872976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anaemia, renal insufficiency and cardiovascular outcome.
    Hegarty J; Foley RN
    Nephrol Dial Transplant; 2001; 16 Suppl 1():102-4. PubMed ID: 11369834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients.
    Weinreich T; De los Ríos T; Gauly A; Passlick-Deetjen J
    Clin Nephrol; 2006 Dec; 66(6):433-9. PubMed ID: 17176915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease?
    Paoletti E; Bellino D; Gallina AM; Amidone M; Cassottana P; Cannella G
    Nephrol Dial Transplant; 2011 Feb; 26(2):670-7. PubMed ID: 20628183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for left ventricular hypertrophy in chronic hemodialysis patients.
    Washio M; Okuda S; Mizoue T; Kiyama S; Ando T; Sanai T; Hirakata H; Nanishi F; Kiyohara C; Ogimoto I; Yoshimura T; Fujishima M
    Clin Nephrol; 1997 Jun; 47(6):362-6. PubMed ID: 9202865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Spinal cord infarction during haemodialysis].
    Finocchiaro P; Garozzo M; Ciccarelli M; Gangemi A; Zoccali C
    G Ital Nefrol; 2003; 20(1):61-4. PubMed ID: 12647288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Valvular calcification and left ventricular modifying in peritoneal dialysis patients.
    Rebić D; Rašić S; Hamzić-Mehmedbašić A; Džemidžić J; Kurtalić E
    Ren Fail; 2015; 37(8):1316-22. PubMed ID: 26287980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cardiac anomalies in chronic renal failure].
    Guérin A; Marchais S; Pannier B; London G
    Presse Med; 2000 Feb; 29(5):274-80. PubMed ID: 10701411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
    Wachtell K; Palmieri V; Gerdts E; Bella JN; Aurigemma GP; Papademetriou V; Dahlöf B; Aalto T; Ibsen H; Rokkedal JE; Devereux RB
    Am J Cardiol; 2010 Oct; 106(7):999-1005. PubMed ID: 20854964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular disease as a late complication of end-stage renal disease in children.
    Groothoff JW; Lilien MR; van de Kar NC; Wolff ED; Davin JC
    Pediatr Nephrol; 2005 Mar; 20(3):374-9. PubMed ID: 15549413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up.
    Stefenelli T; Abela C; Frank H; Koller-Strametz J; Globits S; Bergler-Klein J; Niederle B
    J Clin Endocrinol Metab; 1997 Jan; 82(1):106-12. PubMed ID: 8989242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of various antihypertensive agents on cardiovascular risk factors in patients with renal failure.
    Zarama M; Raij L
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):100-7. PubMed ID: 8494007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):383-7. PubMed ID: 12908173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular problems in the choice of dialysis therapy for the elderly.
    Maiorca R
    Contrib Nephrol; 1994; 106():74-83. PubMed ID: 8174382
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nocturnal blood pressure non-dipping is not associated with increased left ventricular mass index in hypertensive children without end-stage renal failure.
    Seeman T; Hradský O; Gilík J
    Eur J Pediatr; 2016 Aug; 175(8):1091-7. PubMed ID: 27344339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac valve calcifications and left ventricular hypertrophy in hemodialysis patients.
    Strózecki P; Odrowaz-Sypniewska G; Manitius J
    Ren Fail; 2005; 27(6):733-8. PubMed ID: 16350826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aortic valve sclerosis: is it a cardiovascular risk factor or a cardiac disease marker?
    Palmiero P; Maiello M; Passantino A; Wasson S; Reddy HK
    Echocardiography; 2007 Mar; 24(3):217-21. PubMed ID: 17313631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Massive left atrial calcification and devastating systemic emboli in a patient with chronic renal failure.
    Lahey T; Horton S
    Am J Kidney Dis; 2002 Aug; 40(2):416-9. PubMed ID: 12148118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.